More than 200 symptoms have been associated with long COVID, including chest pain, nausea, fatigue, and cognitive impairment.2 Previous studies have shown that vaccination reduces the risk of long COVID, but can’t eliminate the risk entirely. “Anecdotal reports suggest that nirmatrelvir may improve Long COVID symptoms. A long COVID symptom survey was given to the participants, of which 353 treated patients and 1259 untreated patients responded. Of the participants who responded to the survey, investigators found that 16.1% of patients treated with Paxlovid reported long COVID symptoms. Krigel M. Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID.

Source: ABC News January 04, 2024 22:22 UTC